Ligand Pharmaceuticals, Inc. (LGND)
190.43
+1.36
(+0.72%)
USD |
NASDAQ |
Jan 02, 11:48
Ligand Pharmaceuticals Market Cap: 3.748B for Jan. 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 262.60B |
| Johnson & Johnson | 497.66B |
| Inspire Medical Systems, Inc. | 2.700B |
| Elanco Animal Health, Inc. | 11.03B |
| Alnylam Pharmaceuticals, Inc. | 52.79B |
Market Cap Related Metrics
| PE Ratio | 91.65 |
| PS Ratio | 14.92 |
| Price to Book Value | 3.945 |
| Price to Free Cash Flow | 183.44 |
| Price | 190.43 |
| Earnings Yield | 1.09% |
| Operating PE Ratio | 129.92 |
| Normalized PE Ratio | 844.10 |